emerg
virus
bacteria
constitut
seriou
public
health
problem
like
becom
global
safeti
challeng
next
decad
face
situat
need
search
new
antivir
antibiot
emerg
antibiot
clinic
develop
belong
exist
antibiot
class
new
compound
direct
novel
target
fernand
marten
block
cellular
pathway
use
pathogen
combin
therapi
sever
target
interest
strategi
treat
viral
bacteri
infect
avoid
antivir
antibiot
resist
classic
studi
interact
focus
protein
nucleic
acid
pathogen
host
howev
recent
year
lipidom
gain
import
virolog
bacteriolog
lipid
much
structur
compon
membran
molecul
energi
storag
also
play
import
role
cellular
signal
regulatori
process
healthi
infect
cell
lipid
composit
membran
affect
morpholog
biophys
properti
charg
curvatur
width
pack
defect
fluiditi
studi
chang
lipid
biosynthesi
pathway
transport
infect
cell
promis
research
field
mani
virus
bacteria
manipul
host
membran
lipid
flow
toledo
benach
van
der
schaar
dorobantu
albulescu
strate
van
kuppeveld
review
summaris
main
pathway
lipid
synthesi
transport
hijack
virus
bacteria
drug
interfer
gener
process
gpl
major
compon
biolog
membran
structur
base
polar
group
head
defin
charg
shape
properti
allow
interact
water
molecul
near
extern
leaflet
membran
pair
fa
hydrophob
tail
step
gpl
biosynthesi
reli
fa
avail
order
gener
larger
pool
fa
hcv
directli
induc
overexpress
fa
synthas
fasn
key
multienzym
complex
fa
synthesi
therefor
gpl
possibl
mechan
hcv
infect
alter
cellular
lipid
profil
liver
caus
diseas
steatosi
yang
et
al
denv
nonstructur
protein
respons
fasn
recruit
replic
factori
heaton
et
al
infect
cellular
membran
show
enrich
unsatur
phospholipid
lipid
signal
molecul
sphingomyelin
sm
perera
et
al
two
relat
flavivirus
wnv
usutu
viru
usuv
blazquez
jimenez
de
oya
saiz
nonrel
alphanodaviru
fhv
kampmuel
miller
also
show
rna
replic
depend
fa
synthesi
thu
modul
fa
synthesi
effect
antivir
strategi
denv
wnv
usuv
fhv
virus
sensit
inhibitori
effect
cerulenin
two
specif
inhibitor
fasn
cerulenin
natur
product
fungu
cephalosporium
caerulen
inactiv
synthas
activ
fasn
synthet
inhibitor
also
inactiv
enoyl
reductas
thioesteras
partial
activ
fasn
rate
inactiv
synthas
rendina
cheng
design
less
reactiv
safer
classic
inhibitor
cerulenin
appropri
membran
pack
fluiditi
essenti
viral
rna
replic
membran
properti
mostli
depend
satur
grade
length
fa
hydrophob
tale
desaturas
enzym
biosynthesi
monounsatur
fa
satur
fa
precursor
catalys
format
bond
posit
stearoyl
brome
mosaic
viru
bmv
requir
unsatur
fa
mutat
host
fa
desaturas
inhibit
bmv
replic
lee
ishikawa
ahlquist
synthet
inhibitor
develop
specif
block
proven
impair
hcv
denv
infect
cell
cultur
gullberg
et
al
nguyen
et
al
inhibitor
claim
promis
candid
treat
variou
diseas
includ
cancer
alzheim
diseas
viral
infect
recent
novel
inhibitor
develop
report
review
uto
pc
phosphatidylethanolamin
pe
abund
gpl
cell
synthes
two
differ
metabol
rout
cholin
ethanolamin
polar
head
diacylglycerol
backbon
kennedi
pathway
exploit
way
mammalian
cell
pathway
main
pc
sourc
yeast
altern
pathway
consist
lineal
rout
pe
suffer
three
consecut
methyl
mediat
protein
becom
pc
review
henri
kohlwein
carman
global
pc
synthesi
significantli
enhanc
infect
mani
ssrna
virus
denv
fhv
polioviru
hcv
castorena
stapleford
miller
vanc
trip
paddon
zhang
et
al
moreov
bmv
replic
protein
interact
recruit
site
viral
replic
delet
yeast
mutant
bmv
replic
inhibit
zhang
et
al
hand
plant
tombusvirus
tbsv
cucumb
necrosi
viru
carnat
italian
ringspot
viru
unrel
insect
nodamura
viru
requir
high
level
pe
viral
replic
site
virus
take
advantag
increas
pe
level
yeast
cell
wherea
deplet
pe
level
reduc
viral
replic
xu
nagi
pe
small
head
result
conic
shape
propos
contribut
induct
characterist
neg
curvatur
vesicl
spherul
vrc
addit
replic
complex
tbsv
rna
polymeras
rdrp
stimul
upon
pe
bind
xu
nagi
inhibit
phosphatidylglycerol
although
investig
need
identifi
particular
pc
pe
synthesi
pathway
use
differ
virus
fact
one
pathway
could
suppli
physiolog
function
provid
opportun
develop
antivir
target
enzym
subvert
virus
exampl
enterovirus
envelop
virus
accumul
phosphatidylserin
ps
vrc
subdomain
amara
mercer
ps
accumul
usual
associ
ps
uptak
apoptot
mimicri
discuss
cholesterol
sl
content
biolog
membran
defin
import
physic
biolog
properti
lipid
homogen
distribut
membran
togeth
constitut
domain
lipid
raft
involv
membran
traffick
cell
signal
cholesterol
critic
membran
compon
determin
membran
fluiditi
help
stabilis
curvatur
pack
defect
membran
regul
format
function
complex
lipid
protein
virus
take
advantag
properti
make
specialis
membran
platform
rna
replic
viru
assembl
lipid
raft
proven
particip
key
step
life
virus
entri
rna
translat
viru
progeni
assembl
egress
shahsavandi
ebrahimi
hasaninejad
farahani
arbovirus
cholesterol
play
import
role
process
viru
entri
cell
exampl
gc
structur
protein
rift
valley
fever
viru
directli
recognis
bind
gpl
plasma
membran
insert
gc
follow
accumul
cholesterol
local
membran
reorganis
et
al
deplet
cholesterol
consequ
disrupt
lipid
raft
decreas
infect
newcastl
diseas
viru
wnv
hcv
bovin
parainfluenza
viru
mainli
block
viru
entri
cell
kapadia
barth
baumert
mckeat
chisari
li
yu
hou
mackenzi
khromykh
parton
martin
holguera
villar
influenza
synciti
viru
infect
similar
effect
observ
treatment
gemfribrozil
bajimaya
frankl
hayashi
takimoto
natur
elder
fruit
extract
shahsavandi
et
al
cholesterol
pi
pe
concentr
also
membran
vrc
vrc
polioviru
rhinoviru
coxsackieviru
accumul
cholesterol
hsu
et
al
ilnytska
et
al
roulin
et
al
facilit
viral
genom
replic
wnv
modul
host
cholesterol
homeostasi
redistribut
enzym
cellular
cholesterol
replic
site
mackenzi
et
al
moreov
characterist
highli
curv
nanoperiod
cubic
membran
imag
electron
microscopi
cell
infect
sever
ssrna
virus
belong
coronavirida
picornavirida
togavirida
flavivirida
famili
thought
link
chang
cell
cholesterol
metabol
activ
cellular
reductas
reductas
hmgcr
deng
almsherqi
ng
kohlwein
fact
mani
virus
sensit
inhibitor
hmgcr
enzym
cholesterol
biosynthesi
case
statin
use
treat
hypercholesterolaemia
human
statin
act
competit
inhibit
hmgcr
molecular
structur
similar
statin
fit
catalyt
activ
site
enzym
compet
nativ
substrat
competit
reduc
rate
hmgcr
produc
mevalon
next
molecul
cascad
eventu
gener
cholesterol
stancu
sima
thu
statin
deplet
cholesterol
disrupt
lipid
raft
exampl
wnv
denv
tbsv
inhibit
lovastatin
mackenzi
et
al
rothwel
et
al
sharma
sasvari
nagi
del
angel
denv
human
immunodefici
inhibit
simvastatin
et
al
delucia
rinaldo
rappocciolo
hcv
also
sensit
differ
statin
amemiya
et
al
kim
et
al
rao
pandya
lipidom
studi
shown
increas
content
ceramid
cer
sm
cell
cer
specif
associ
wnv
replic
viral
particl
biogenesi
sm
enrich
vrc
membran
virus
phylogenet
relat
wnv
denv
hcv
et
al
hcv
rdrp
activ
sm
bind
twenti
sm
molecul
interact
specif
bind
domain
structur
hcv
rdrp
chang
conform
catalyt
pocket
lead
rna
recruit
replic
weng
et
al
inhibit
differ
enzym
mediat
sl
biosynthesi
decreas
infect
differ
virus
de
novo
synthesi
sl
initi
er
synthesi
sphinganin
serin
enzym
serin
palmitoyltransferas
three
inhibitor
serin
palmitoyltransferas
describ
present
antivir
activ
hcv
hepat
b
viru
wnv
myriocin
aizaki
et
al
aktep
pham
mackenzi
amemiya
et
al
sakamoto
et
al
tatematsu
tanaka
sugiyama
sudoh
mizokami
weng
et
al
sphinganin
acyl
transform
cer
cer
synthas
cer
deliv
golgi
complex
convert
sm
sm
synthas
complex
glycosphingolipid
uridin
cer
synthas
pharmacolog
inhibit
sm
synthas
inhibit
uridin
cer
synthas
pdmp
respect
reduc
infect
hcv
wnv
khan
et
al
et
al
inhibit
cer
synthas
fumonisin
also
impair
wnv
replic
aktep
et
al
observ
virus
flavivirida
found
sensit
sl
biosynthesi
blockag
lipid
biosynthet
enzym
associ
viral
infect
exampl
hcv
take
advantag
three
lipid
synthesi
enzym
relat
biogenesi
mainten
cellular
lipid
droplet
ld
ld
dynam
organel
enrich
triglycerid
cholesterol
ester
regul
storag
hydrolysi
neutral
lipid
particip
lipid
energi
balanc
signal
cell
immun
protein
storag
traffick
welt
replic
hcv
protein
target
ld
viru
assembl
take
place
pharmacolog
inhibit
synthetas
diacylglycerol
acyltransferas
cholesterol
acyltransferas
result
blockad
virion
assembl
egress
herker
et
al
liefhebb
hagu
zhang
wakelam
mclauchlan
target
synthesi
lipid
store
ld
might
altern
therapeut
treatment
chronic
hcv
infect
host
factor
involv
recruit
hcv
ld
phospholipas
menzel
picornavirus
also
shown
utilis
differ
phospholipas
case
enzym
assist
genom
deliveri
virion
cytoplasm
entri
cell
stare
et
al
lipid
recent
emerg
signal
molecul
involv
nearli
aspect
cellular
regul
product
describ
play
key
regulatori
role
wide
rang
cellular
activ
includ
membran
traffick
biogenesi
via
recruit
effector
protein
relat
lipid
biosynthesi
transport
major
pool
synthes
golgi
membran
pi
type
distinguish
two
differ
isoform
mani
differ
virus
exploit
host
kinas
exampl
hcv
enterovirus
picornavirus
stimul
kinas
gener
situ
replic
site
local
increas
signific
impact
membran
remodel
assembl
vrc
viral
genom
replic
hcv
nonstructur
protein
encephalomyocard
viru
emcv
nonstructur
protein
recruit
activ
dorobantu
et
al
reiss
et
al
howev
enterovirus
use
nonstructur
protein
recruit
vrc
hsu
et
al
specif
target
protein
kinas
inhibitor
compound
enviroxim
use
antipolioviru
compound
arita
et
al
synthet
compound
arita
et
al
roulin
et
al
antivir
differ
enterovirus
hand
pharmacolog
inhibit
decreas
infect
saffold
viru
emcv
hcv
dorobantu
et
al
tyrphostin
known
epiderm
growth
factor
receptor
inhibitor
anticanc
chemotherapi
agent
also
inhibit
activ
vitro
cell
cultur
impair
replic
emcv
hcv
dorobantu
et
al
contrast
inhibit
isoform
compound
effici
enterovirus
includ
polioviru
coxsackieviru
human
rhinovirus
arita
arita
et
al
roulin
et
al
hcv
hsu
et
al
lack
specif
isoform
fact
inhibit
high
concentr
rais
concern
use
antivir
agent
bish
sy
siddiqui
although
vitro
studi
found
signific
problem
cellular
viabil
vivo
studi
shown
anim
treat
relat
small
inhibitor
suffer
advers
effect
howev
given
kinas
use
mani
differ
virus
attract
target
develop
antivir
inhibitor
less
toxic
cellular
kinas
current
consider
rutaganira
et
al
van
der
schaar
et
al
protein
osbp
exchang
cholesterol
mcss
golgi
apparatu
er
transport
cholesterol
osbp
highli
depend
activ
level
golgi
membran
synthes
surfac
golgi
membran
lipid
serv
anchor
osbp
drive
transport
accumul
cholesterol
differ
virus
belong
picornavirida
famili
enteroviru
polioviru
emcv
well
hcv
anoth
posit
strand
nonrel
viru
use
pathway
arita
van
der
schaar
et
al
due
observ
delet
osbp
compromis
cellular
viabil
probabl
redund
ltp
could
make
function
interest
studi
osbp
target
antivir
grown
date
three
differ
drug
develop
specif
inhibit
osbp
itraconazol
bind
osbp
hydrophob
pocket
compet
cholesterol
success
test
enteroviru
emcv
hcv
albulescu
et
al
albulescu
et
al
strate
et
al
wang
et
al
cer
transfer
protein
cert
adaptor
protein
mediat
traffic
sl
precursor
ltp
accumul
sl
replic
site
good
target
interfer
flavivirus
cert
respons
transfer
cer
er
golgi
synthesi
complex
sl
take
place
hanada
et
al
cert
necessari
hcv
egress
bish
et
al
pharmacolog
inhibit
synthet
compound
dramat
impair
hcv
releas
aizaki
et
al
yasuda
et
al
moreov
cert
osbp
regul
protein
kinas
phosphoryl
form
ltp
inact
amako
sy
siddiqui
drug
interf
host
protein
kinas
inhibitor
harikumar
et
al
might
becom
effici
antivir
dock
golgi
shuttl
glucosylceramid
godi
et
al
substrat
subset
complex
glycosphingolipid
local
hcv
replic
site
mediat
accumul
lactosylceramid
vrc
deplet
disrupt
hcv
replic
complex
impair
hcv
replic
khan
et
al
type
protein
discov
studi
human
neurodegen
diseas
character
disrupt
subcellular
cholesterol
transport
glycoprotein
transmembran
domain
local
late
endosom
transient
lysosom
network
act
tandem
carri
transfer
extracellular
recycl
free
cholesterol
endosomallysosom
system
network
er
ioannou
cell
receptor
ebola
viru
marburg
viru
filovirus
carett
et
al
develop
specif
inhibitor
lu
et
al
administr
multipl
cation
amphiphil
induc
accumul
cholesterol
endosom
lysosom
inhibit
ebola
entri
infect
shoemak
et
al
target
also
impair
replic
rna
virus
denv
poh
et
al
hepat
e
viru
yin
ambardekar
lu
feng
found
cellular
receptor
virus
advers
effect
viral
replic
treatment
deplet
must
due
effect
postentri
step
case
hcv
take
advantag
cellular
endosom
exosom
pathway
egress
host
cell
block
releas
viral
particl
inhibit
therefor
transport
function
multivesicular
bodi
lead
accumul
matur
viral
particl
exosom
moreov
lead
format
larg
dysfunct
structur
mediat
degrad
viral
particl
elgner
et
al
ps
anion
phospholipid
usual
orient
cytosol
side
plasma
membran
patholog
cellular
stress
situat
ps
molecul
flip
expos
cell
surfac
serv
like
alert
flag
detect
immun
system
ps
exposur
link
apoptosi
infect
cancer
birg
et
al
ps
anion
lipid
present
membran
mani
envelop
rna
virus
includ
denv
wnv
chikungunya
ebola
lassa
fever
viru
human
immunodefici
viru
dna
virus
vaccinia
envelop
virus
recognis
cell
surfac
ps
receptor
mediat
viru
uptak
process
known
viral
apoptosi
mimicri
amara
mercer
expos
anion
phospholipid
infect
cell
may
provid
new
target
gener
antivir
agent
multipl
class
virus
soar
king
thorp
bavituximab
monoclon
antibodi
success
block
infect
envelop
virus
ebola
lassa
fever
virus
vitro
assay
small
anim
model
dowal
et
al
soar
et
al
molecular
mechan
ps
accumul
viral
bud
site
yet
well
understood
recent
protein
shown
facilit
exchang
membran
mcss
chung
et
al
anoth
studi
suggest
phospholipid
enzym
flip
ps
membran
leaflet
might
particip
ps
extracellular
exposur
cell
infect
herp
viru
inhibit
phospholipid
antagonist
prevent
exposur
ps
cell
surfac
reduc
viru
infect
cheshenko
pierc
herold
de
novo
cholesterol
biosynthesi
occur
er
convers
mevalon
hmgcr
cellular
cholesterol
level
also
increas
uptak
cholesterol
bound
lipoprotein
ldl
via
ldl
receptor
cellular
cholesterol
level
high
transport
cell
broken
bile
acid
steroid
esterifi
store
ld
eukaryot
cell
cholesterol
sl
main
compon
membran
microdomain
known
lipid
raft
microdomain
contain
tightli
pack
receptor
cluster
signal
protein
involv
mani
signal
transduct
pathway
anaplasma
phagocytophilum
brucella
speci
enter
cell
lipid
manner
naroeni
port
xiong
lin
rikihisa
pharmacolog
disrupt
cholesterol
flow
impair
assembl
lipid
raft
thu
treatment
xiong
rikihisa
ketoconazol
filipin
iii
watarai
et
al
watarai
makino
fujii
okamoto
shirahata
make
bacteria
incap
infect
cell
chlamydia
develop
differ
strategi
incorpor
lipid
via
vesicular
nonvesicular
transport
hackstadt
scidmor
rockey
hatch
mcclarti
wyli
hatch
mcclarti
cholesterol
deplet
jutra
abrami
korhonen
et
al
simvastatin
erkkila
et
al
beatti
cholesterol
acyltransferas
inhibitor
peter
byrn
shown
elementari
bodi
extracellular
infecti
stage
chlamydia
attach
site
plasma
membran
howev
import
lipid
raft
chlamydia
entri
matter
controversi
studi
shown
chlamydia
enter
cell
way
depend
lipid
raft
gabel
elwel
van
ijzendoorn
engel
norkin
wolfrom
stuart
contradictori
result
attribut
studi
variou
bacteri
isol
differ
host
cell
enter
cell
phagocytophilum
brucella
mycobacterium
salmonella
chlamydia
coxiella
burnetii
establish
replic
inclus
compart
deriv
phagosom
organel
endocyt
pathway
berthiaum
mock
swanson
miller
heinzen
scidmor
rockey
hackstadt
niu
yamaguchi
rikihisa
oh
et
al
although
bacteria
lack
gene
cholesterol
biosynthesi
cholesterol
content
increas
infect
cell
particular
chlamydia
spp
c
burnetii
phagocytophilum
modul
host
cholesterol
homeostasi
level
gene
transcript
ldl
receptor
hmgcr
gilk
lin
rikihisa
chlamydia
downregul
cholesterol
efflux
requir
de
novo
cholesterol
synthesi
bashmakov
zigangirova
pashko
kapotina
petyaev
wherea
phagocytophilum
alter
ldl
uptak
infect
cell
caus
twofold
increas
cholesterol
content
xiong
et
al
c
burnetii
increas
cholesterol
content
infect
cell
czyz
et
al
howe
heinzen
earli
stage
infect
inclus
membran
c
burnetii
low
level
cholesterol
later
stage
amount
cholesterol
increas
suggest
tempor
regul
cholesterol
biosynthesi
uptak
c
burnetii
shown
sensit
treatment
statin
howe
heinzen
mycobacterium
salmonella
need
lipid
raft
entri
intracellular
cholesterol
import
infect
mention
mycobacterium
synthes
cholesterol
need
obtain
cholesterol
host
altern
mean
gene
cluster
system
import
cholesterol
bacteria
disrupt
cholesterol
metabol
diminish
mycobacterium
entri
kaul
anand
verma
replic
de
chastelli
thilo
miner
chang
pandey
sassetti
sherman
mohn
et
al
parihar
et
al
russel
cardona
kim
allain
altar
subsequ
stage
infect
nesbitt
et
al
pandey
sassetti
salmonella
use
pathogen
island
type
iii
secret
system
local
lumen
inclus
mediat
esterif
cholesterol
haraga
ohlson
miller
nawabi
catron
haldar
pharmacolog
disrupt
cholesterol
statin
catron
et
al
huang
reduc
intracellular
salmonella
growth
bacteria
pseudomona
aeruginosa
kowalski
pier
staphylococcu
pneumonia
bergman
et
al
staphylococcu
aureu
jerwood
cohen
escherichia
coli
klebsiella
pneumonia
also
suscept
treatment
statin
pharmacolog
inhibit
cholesterol
genet
deplet
experi
confirm
target
cholesterol
lead
effici
strategi
bacteria
reduc
entri
replic
host
cell
although
incorpor
cer
lipid
raft
essenti
initi
cell
defenc
pathogen
salmonella
huang
mccollist
myer
voelker
process
use
bacteria
infect
cell
mycobacterium
infect
asm
contribut
fusion
vacuol
phagosom
process
mediat
elimin
bacteria
vazquez
et
al
mycobacterium
avoid
host
defenc
via
pi
signal
thu
mycobacterium
tuberculosi
synthes
glycosyl
phosphoinositid
lipoarabinomannan
manlam
beatti
et
al
fratti
chua
vergn
deret
furthermor
phosphatas
activ
sapm
mptpb
mptpa
reduc
amount
ptdin
p
vacuol
surfac
chua
deret
manlam
phosphatas
effector
interfer
phagosom
matur
degrad
bacteria
castandet
et
al
singh
et
al
interestingli
asm
also
import
mycobacterium
infect
pharmacolog
inhibit
asm
imipramin
godbol
et
al
infect
mice
utermohlen
herz
schramm
kronk
show
growth
tuberculosi
mycobacterium
smegmati
mycobacterium
avium
block
moreov
mice
resist
mycobacterium
lethal
infect
mice
addit
neisseria
pseudomona
trigger
asm
activ
cer
releas
assembl
raft
essenti
infect
grassm
et
al
grassm
et
al
hauck
et
al
platform
serv
scaffold
recruit
cellular
receptor
cystic
fibrosi
transmembran
conduct
regul
use
pseudomona
enter
cell
schroeder
et
al
defici
asm
specif
pharmacolog
inhibit
block
neisseria
grassm
et
al
hauck
et
al
simoni
hebl
gulbin
pseudomona
becker
et
al
cremesti
et
al
riethmul
et
al
entri
infect
asm
inhibitor
also
effect
bacteria
aureu
peng
et
al
e
coli
falcon
et
al
demonstr
potenti
antibiot
chlamydia
incorpor
lipid
storag
organel
inclus
lumen
cocchiaro
kumar
fischer
hackstadt
valdivia
machineri
synthet
gpl
pe
phosphatidylglycerol
ps
need
hijack
lipid
fa
chlamydia
also
need
transport
cholesterol
sl
bacteri
cell
wall
yao
cherian
frank
rock
yao
dodson
frank
rock
close
associ
golgi
apparatu
sm
synthet
chlamydia
inclus
chlamydia
intercept
exocyt
transport
vesicl
redirect
inclus
wolf
hackstadt
purpos
chlamydia
also
use
cert
whose
role
infect
discuss
lipid
signal
molecul
involv
wide
rang
cellular
process
eukaryot
signal
transduct
cytoskeleton
rearrang
membran
dynam
plasma
membran
enrich
pi
pi
p
phagosom
earli
endosom
enrich
pi
p
multivesicular
bodi
late
endosom
contain
pi
p
pi
bacteria
subvert
ptdin
flow
encod
enzym
princip
phosphatas
alter
express
local
host
protein
modul
pi
intracellular
level
presenc
differ
speci
lipid
surfac
bacteri
inclus
creat
optim
recruit
specif
protein
shoot
signal
cascad
avoid
cellular
defenc
two
mayor
signal
cascad
propos
listeria
invas
mengaud
et
al
shen
naujoka
park
ireton
two
pathway
depend
virul
factor
inia
inib
inib
interact
natur
receptor
met
marino
braun
cossart
ghosh
shen
et
al
trigger
activ
transloc
listeria
monocytogen
entri
site
subsequ
signal
cascad
produc
increas
lipid
product
particular
pi
ireton
et
al
ireton
payrastr
cossart
recruit
effector
actin
reorganis
cascad
cytoskelet
rearrang
critic
l
monocytogen
invas
inhibitor
wortmannin
block
infect
ireton
et
al
shigella
infect
site
internalis
coloc
pi
p
produc
particip
bacteri
phosphatas
ipgd
accumul
plasma
membran
reduc
tether
forc
favour
entri
pathway
activ
regul
antiapoptot
effector
trigger
howev
block
wortmannin
affect
shigella
entri
suggest
activ
involv
invas
later
step
infect
lafont
tran
van
nhieu
hanada
sansonetti
van
der
goot
pendari
et
al
phagocytophilum
also
take
advantag
pathway
delay
apoptosi
someth
observ
experi
pharmacolog
inhibit
khanal
sultana
catrava
carlyon
neelakanta
sarkar
et
al
brucella
also
requir
activ
enter
cell
replic
et
al
salmonella
modul
signal
differ
stage
infect
via
bacteri
phosphatas
effector
sopb
process
convert
pi
pi
plasma
membran
produc
doubl
effect
first
reduct
interact
membran
cytoskeleton
lead
bacteri
invas
terebiznik
et
al
second
recruit
akt
activ
cell
surviv
pathway
avoid
apoptosi
sopb
also
reduc
pi
ps
level
salmonella
vacuol
surfac
charg
diminish
avoid
fusion
lysosom
bakowski
et
al
anoth
essenti
sopb
function
salmonella
replic
recruit
inclus
surfac
requir
maintain
high
level
pi
p
bujni
et
al
hernandez
hueffer
wenk
galan
two
studi
auwet
et
al
auwet
yu
arena
guttman
finlay
show
ssel
anoth
salmonella
effector
interact
lipid
transfer
protein
osbp
enhanc
salmonella
replic
probabl
modifi
lipid
composit
replic
vacuol
contrast
mycobacterium
alter
pi
p
level
dual
strategi
mycobacterium
encod
differ
phosphatas
effector
arrest
phagosom
matur
avoid
elimin
reduc
amount
pi
p
mycobacterium
inclus
surfac
castandet
et
al
singh
et
al
mycobacterium
also
express
glycosyl
pi
analogu
manlam
inhibit
activ
kinas
involv
pi
p
product
chlamydia
activ
signal
pathway
et
al
zou
et
al
favour
infect
surviv
shown
import
chlamydia
listeria
infect
addit
activ
requir
listeria
invas
blockad
impair
entri
without
perturb
plasma
membran
content
pi
pi
et
al
although
particip
listeria
infect
well
understood
result
suggest
postentri
signal
role
legionella
modifi
pi
flow
number
effector
interfer
endocyt
secretori
pathway
commun
er
legionella
pneumophila
hijack
pc
diacylglycerol
vacuol
membran
viner
chetrit
ehrlich
segal
furthermor
known
l
pneumophila
enrich
inclus
membran
pi
p
manner
brombach
et
al
weber
ragaz
reu
nyfel
hilbi
addit
treatment
inhibitor
reduc
l
pneumophila
replic
hubber
et
al
confirm
import
legionella
infect
howev
requir
l
pneumophila
entri
replic
matter
debat
charpenti
et
al
khelef
shuman
maxfield
tachado
samrakandi
cirillo
weber
et
al
chlamydia
recruit
high
level
membran
inclus
recruit
lipid
transfer
protein
osbp
way
although
role
still
unclear
osbp
probabl
particip
inclus
membran
remodel
modifi
lipid
composit
moorhead
jung
smirnov
kaufer
scidmor
someth
could
make
chlamydia
sensit
inhibitor
osbp
pharmacolog
inhibit
genet
defici
studi
show
use
phagocytophilum
brucella
recruit
produc
accumul
cholesterol
inclus
phagocytophilum
moreov
treatment
inhibitor
block
transport
cholesterol
bacteri
inclus
stop
bacteri
growth
evidenc
essenti
role
ltp
infect
xiong
et
al
xiong
rikihisa
case
brucella
lipid
raft
import
entri
bacteria
host
cell
watarai
makino
michikawa
et
al
import
mainten
lipid
raft
target
block
brucella
infect
therefor
mice
resist
brucella
infect
watarai
makino
fujii
et
al
effici
also
c
burnetii
chlamydia
trachomati
beatti
howe
heinzen
role
infect
still
unknown
mention
cert
transport
cer
er
membran
golgi
apparatu
sm
synthas
transform
sm
chlamydia
synthes
sl
essenti
biogenesi
bacteri
inclus
replic
bacteria
van
ooij
et
al
microscopi
immunogold
label
show
cert
recruit
bacteri
inclus
chlamydia
use
cert
transport
cer
er
bacteri
inclus
sm
synthesi
derr
swiss
agaiss
elwel
et
al
sm
incorpor
inclus
membran
bacteri
cell
wall
compound
report
specif
cert
inhibitor
howev
cell
sl
transport
still
work
strongli
impair
transport
carabeo
mead
hackstadt
elwel
et
al
et
al
result
suggest
inhibitor
cer
transport
cert
protein
belong
protein
famili
act
cholesterol
sensor
modul
format
mcss
late
endosom
er
recent
report
coxiella
recruit
mcss
form
bacteri
inclus
er
follow
chang
membran
properti
inclus
vacuol
justi
et
al
wallqvist
et
al
attach
vacuol
membran
ankyrin
repeat
involv
interact
specif
function
infect
still
unclear
therapeut
approach
base
specif
factor
interact
promis
avenu
overcom
treatment
failur
infecti
diseas
lipid
gain
import
target
antivir
antibiot
develop
mani
virus
bacteria
use
lipid
build
replic
persist
inhibitor
synthesi
cholesterol
cer
sl
fa
phospholipid
interfer
growth
mani
pathogen
besid
drug
protein
kinas
target
signal
pathway
need
infect
figur
summaris
current
knowledg
host
lipid
synthesi
transport
signal
pathway
use
virus
bacteria
compound
interfer
pathway
may
becom
effici
antivir
antibiot
moreov
drug
test
virus
might
effici
also
bacteria
vice
versa
notabl
target
lipid
transport
may
produc
less
toxic
antivir
antibiot
intracellular
pathogen
depend
specif
ltp
make
although
cell
may
one
ltp
function
within
context
screen
clinic
test
compound
provid
rapid
mean
identifi
undiscov
antivir
antibiot
function
molecul
target
lipid
metabol
flow
author
declar
conflict
interest
